Sarepta Therapeutics Inc (SRPT) — Net Asset Quality Index
Sarepta Therapeutics Inc (SRPT) has a Net Asset Quality Index of 47.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.18 Billion minus total liabilities of $1.67 Billion yields net assets of $1.51 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Sarepta Therapeutics Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sarepta Therapeutics Inc Net Asset Quality Index Over Time (1995–2025)
This chart shows how Sarepta Therapeutics Inc's Net Asset Quality Index has evolved across 31 annual periods from 1995 to 2025. As of March 2026, the index stands at 47.3%, representing net assets of $1.51 Billion against total assets of $3.18 Billion USD. See SRPT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sarepta Therapeutics Inc (1995–2025)
The table below presents the year-by-year Net Asset Quality Index for Sarepta Therapeutics Inc from 1995 to 2025, covering 31 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Sarepta Therapeutics Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.1% | $1.14 Billion | $3.35 Billion | $2.21 Billion | ▼ -4.5 pp |
| 2024 | 38.5% | $1.53 Billion | $3.96 Billion | $2.44 Billion | ▲ +12.2 pp |
| 2023 | 26.3% | $859.34 Million | $3.26 Billion | $2.41 Billion | ▲ +14.0 pp |
| 2022 | 12.3% | $384.95 Million | $3.13 Billion | $2.74 Billion | ▼ -17.2 pp |
| 2021 | 29.5% | $928.01 Million | $3.15 Billion | $2.22 Billion | ▲ +4.0 pp |
| 2020 | 25.5% | $761.76 Million | $2.98 Billion | $2.22 Billion | ▼ -19.4 pp |
| 2019 | 44.9% | $818.19 Million | $1.82 Billion | $1.00 Billion | ▼ -18.0 pp |
| 2018 | 62.9% | $1.03 Billion | $1.64 Billion | $609.80 Million | ▲ +2.5 pp |
| 2017 | 60.3% | $789.22 Million | $1.31 Billion | $518.75 Million | ▼ -19.0 pp |
| 2016 | 79.4% | $336.69 Million | $424.10 Million | $87.41 Million | ▲ +9.9 pp |
| 2015 | 69.5% | $190.35 Million | $273.78 Million | $83.44 Million | ▼ -14.4 pp |
| 2014 | 83.9% | $247.65 Million | $295.03 Million | $47.38 Million | ▼ -0.8 pp |
| 2013 | 84.8% | $247.19 Million | $291.57 Million | $44.38 Million | ▲ +24.4 pp |
| 2012 | 60.3% | $123.68 Million | $204.99 Million | $81.31 Million | ▲ +3.3 pp |
| 2011 | 57.1% | $31.02 Million | $54.37 Million | $23.35 Million | ▲ +63.2 pp |
| 2010 | -6.1% | $-2.82 Million | $45.98 Million | $48.79 Million | ▼ -45.5 pp |
| 2009 | 39.4% | $23.63 Million | $60.03 Million | $36.40 Million | ▼ -22.2 pp |
| 2008 | 61.6% | $15.73 Million | $25.54 Million | $9.80 Million | ▼ -6.7 pp |
| 2007 | 68.3% | $26.38 Million | $38.64 Million | $12.26 Million | ▼ -24.0 pp |
| 2006 | 92.3% | $37.71 Million | $40.86 Million | $3.15 Million | ▼ -2.8 pp |
| 2005 | 95.1% | $53.66 Million | $56.41 Million | $2.75 Million | ▲ +3.0 pp |
| 2004 | 92.1% | $26.27 Million | $28.52 Million | $2.25 Million | ▲ +0.1 pp |
| 2003 | 92.0% | $43.39 Million | $47.15 Million | $3.75 Million | ▲ +10.0 pp |
| 2002 | 82.1% | $23.48 Million | $28.60 Million | $5.12 Million | ▼ -8.2 pp |
| 2001 | 90.3% | $30.53 Million | $33.82 Million | $3.28 Million | ▼ -4.8 pp |
| 2000 | 95.1% | $33.37 Million | $35.09 Million | $1.72 Million | ▲ +2.8 pp |
| 1999 | 92.2% | $11.90 Million | $12.90 Million | $1.00 Million | ▲ +4.0 pp |
| 1998 | 88.2% | $9.00 Million | $10.20 Million | $1.20 Million | ▼ -9.1 pp |
| 1997 | 97.3% | $18.30 Million | $18.80 Million | $500.00K | ▲ +78.3 pp |
| 1996 | 19.0% | $800.00K | $4.20 Million | $3.40 Million | ▼ -67.9 pp |
| 1995 | 87.0% | $2.00 Million | $2.30 Million | $300.00K | — |